Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Proteostasis Therapeutics Inc    PTI

PROTEOSTASIS THERAPEUTICS INC

(PTI)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/12/2019 04/15/2019 04/16/2019 04/17/2019 04/18/2019 Date
1.33(c) 1.29(c) 1.27(c) 1.26(c) 1.2(c) Last
1 243 905 926 304 773 589 1 188 442 1 456 589 Volume
-2.21% -3.01% -1.55% -0.79% -4.76% Change
More quotes
Financials (USD)
Sales 2019 1,63 M
EBIT 2019 -89,7 M
Net income 2019 -88,2 M
Debt 2019 -
Yield 2019 -
Sales 2020 1,58 M
EBIT 2020 -101 M
Net income 2020 -100 M
Finance 2020 36,7 M
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020
EV / Sales2019 37,7x
EV / Sales2020 15,6x
Capitalization 61,2 M
More Financials
Company
Proteostasis Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in discovery and development of therapeutics that treat diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. It has... 
More about the company
Surperformance© ratings of Proteostasis Therapeutics
Trading Rating : Investor Rating :
More Ratings
Latest news on PROTEOSTASIS THERAPEUTICS
03/29PROTEOSTASIS THERAPEUTICS, INC. : Termination of a Material Definitive Agreement..
AQ
03/25PROTEOSTASIS THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financ..
AQ
03/25PROTEOSTASIS THERAPEUTICS : Announces Broad New Dataset from Proprietary Combina..
PR
03/08PROTEOSTASIS THERAPEUTICS : Management's Discussion and Analysis of Financial Co..
AQ
03/07PROTEOSTASIS THERAPEUTICS : Appoints David Arkowitz to Board of Directors
PR
02/27PROTEOSTASIS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements..
AQ
02/27PROTEOSTASIS THERAPEUTICS : Selected to Join European Consortium to Pioneer Pers..
PR
02/20PROTEOSTASIS THERAPEUTICS : to Present at the 8th Annual SVB Leerink Global Heal..
PR
02/11PROTEOSTASIS THERAPEUTICS, INC. : Change in Directors or Principal Officers (for..
AQ
02/11Proteostasis Therapeutics Up 25%; BlackRock Disclosed 5.9% Stake Friday
DJ
More news
Sector news : Bio Therapeutic Drugs
04/16GILEAD SCIENCES : Insitro to Collaborate on Nonalcoholic Steatohepatitis
DJ
04/15PATRICK THOMAS : Novartis Files Application for Macular Degeneration Treatment
DJ
04/12GILEAD SCIENCES : Novo Nordisk Plan NASH Collaboration
DJ
04/08GSK wins U.S. nod for two-drug HIV combination
RE
04/08Sanofi, Alnylam Complete Research Phase of Rare Disease Alliance
DJ
More sector news : Bio Therapeutic Drugs
Chart PROTEOSTASIS THERAPEUTICS INC
Duration : Period :
Proteostasis Therapeutics Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROTEOSTASIS THERAPEUTICS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 11,6 $
Spread / Average Target 867%
EPS Revisions
Managers
NameTitle
Meenu Chhabra Karson President, Chief Executive Officer & Director
Michael James Barrett Chairman
Marija Zecevic Chief Operating Officer
Helen M. Boudreau Treasurer, Chief Financial & Accounting Officer
Po-Shun Lee Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PROTEOSTASIS THERAPEUTICS INC-62.96%61
GILEAD SCIENCES0.64%80 255
VERTEX PHARMACEUTICALS1.48%42 991
REGENERON PHARMACEUTICALS-10.75%35 789
GENMAB5.11%10 418
SAREPTA THERAPEUTICS INC6.88%8 594